Jessica Y Breland1,2, Ciaran S Phibbs3,4, Katherine J Hoggatt5,6, Donna L Washington5,7, Jimmy Lee3, Sally Haskell8,9,10, Uchenna S Uchendu11, Fay S Saechao3, Laurie C Zephyrin8,12, Susan M Frayne3,4. 1. VA HSR&D Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, 795 Willow Road (MPD-152), Menlo Park, CA, 94025, USA. jessica.breland@va.gov. 2. Stanford University School of Medicine, Stanford, CA, USA. jessica.breland@va.gov. 3. VA HSR&D Center for Innovation to Implementation (Ci2i), VA Palo Alto Health Care System, 795 Willow Road (MPD-152), Menlo Park, CA, 94025, USA. 4. Stanford University School of Medicine, Stanford, CA, USA. 5. VA HSR&D Center for the Study of Healthcare Innovation, Implementation & Policy (CSHIIP), VA Greater Los Angeles Healthcare System, Sepulveda, CA, USA. 6. Department of Epidemiology, UCLA Fielding School of Public Health, Los Angeles, CA, USA. 7. David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, CA, USA. 8. United States Department of Veterans Affairs Central Office, Women's Health Services, Washington, DC, USA. 9. West Haven VA, West Haven, CT, USA. 10. Yale University School of Medicine, New Haven, CT, USA. 11. United States Department of Veterans Affairs Central Office, Office of Health Equity, Washington, DC, USA. 12. New York University School of Medicine, New York, NY, USA.
Abstract
BACKGROUND: Most US adults are overweight or obese. Understanding differences in obesity prevalence across subpopulations could facilitate the development and dissemination of weight management services. OBJECTIVES: To inform Veterans Health Administration (VHA) weight management initiatives, we describe obesity prevalence among subpopulations of VHA patients. DESIGN: Cross-sectional descriptive analyses of fiscal year 2014 (FY2014) national VHA administrative and clinical data, stratified by gender. Differences ≥5% higher than the population mean were considered clinically significant. PARTICIPANTS: Veteran VHA primary care patients with a valid weight within ±365 days of their first FY2014 primary care visit, and a valid height (98% of primary care patients). MAIN MEASURES: We used VHA vital signs data to ascertain height and weight and calculate body mass index, and VHA outpatient, inpatient, and fee basis data to identify sociodemographic- and comorbidity-based subpopulations. KEY RESULTS: Among nearly five million primary care patients (347,112 women, 4,567,096 men), obesity prevalence was 41% (women 44%, men 41%), and overweight prevalence was 37% (women 31%, men 38%). Across the VHA's 140 facilities, obesity prevalence ranged from 28% to 49%. Among gender-stratified subpopulations, obesity prevalence was high among veterans under age 65 (age 18-44: women 40%, men 46%; age 45-64: women 49%, men 48%). Obesity prevalence varied across racial/ethnic and comorbidity subpopulations, with high obesity prevalence among black women (51%), women with schizophrenia (56%), and women and men with diabetes (68%, 56%). CONCLUSIONS: Overweight and obesity are common among veterans served by the VHA. VHA's weight management initiatives have the potential to avert long-term morbidity arising from obesity-related conditions. High-risk groups-such as black women veterans, women veterans with schizophrenia, younger veterans, and Native Hawaiian/Other Pacific Islander and American Indian/Alaska Native veterans-may require particular attention to ensure that systems improvement efforts at the population level do not inadvertently increase health disparities.
BACKGROUND: Most US adults are overweight or obese. Understanding differences in obesity prevalence across subpopulations could facilitate the development and dissemination of weight management services. OBJECTIVES: To inform Veterans Health Administration (VHA) weight management initiatives, we describe obesity prevalence among subpopulations of VHA patients. DESIGN: Cross-sectional descriptive analyses of fiscal year 2014 (FY2014) national VHA administrative and clinical data, stratified by gender. Differences ≥5% higher than the population mean were considered clinically significant. PARTICIPANTS: Veteran VHA primary care patients with a valid weight within ±365 days of their first FY2014 primary care visit, and a valid height (98% of primary care patients). MAIN MEASURES: We used VHA vital signs data to ascertain height and weight and calculate body mass index, and VHA outpatient, inpatient, and fee basis data to identify sociodemographic- and comorbidity-based subpopulations. KEY RESULTS: Among nearly five million primary care patients (347,112 women, 4,567,096 men), obesity prevalence was 41% (women 44%, men 41%), and overweight prevalence was 37% (women 31%, men 38%). Across the VHA's 140 facilities, obesity prevalence ranged from 28% to 49%. Among gender-stratified subpopulations, obesity prevalence was high among veterans under age 65 (age 18-44: women 40%, men 46%; age 45-64: women 49%, men 48%). Obesity prevalence varied across racial/ethnic and comorbidity subpopulations, with high obesity prevalence among black women (51%), women with schizophrenia (56%), and women and men with diabetes (68%, 56%). CONCLUSIONS: Overweight and obesity are common among veterans served by the VHA. VHA's weight management initiatives have the potential to avert long-term morbidity arising from obesity-related conditions. High-risk groups-such as black women veterans, women veterans with schizophrenia, younger veterans, and Native Hawaiian/Other Pacific Islander and American Indian/Alaska Native veterans-may require particular attention to ensure that systems improvement efforts at the population level do not inadvertently increase health disparities.
Entities:
Keywords:
health disparities; obesity; population health; veterans; women
Authors: Tracey J Smith; Bernadette P Marriott; Laura Dotson; Gaston P Bathalon; Leslee Funderburk; Alan White; Louise Hadden; Andrew J Young Journal: Obesity (Silver Spring) Date: 2012-02-08 Impact factor: 5.002
Authors: Sandra L Jackson; Qi Long; Mary K Rhee; Darin E Olson; Anne M Tomolo; Solveig A Cunningham; Usha Ramakrishnan; K M Venkat Narayan; Lawrence S Phillips Journal: Lancet Diabetes Endocrinol Date: 2015-02-02 Impact factor: 32.069
Authors: Wei Yu; Arliene Ravelo; Todd H Wagner; Ciaran S Phibbs; Aman Bhandari; Shuo Chen; Paul G Barnett Journal: Med Care Res Rev Date: 2003-09 Impact factor: 3.929
Authors: Lara L Roberson; Ehimen C Aneni; Wasim Maziak; Arthur Agatston; Theodore Feldman; Maribeth Rouseff; Thinh Tran; Michael J Blaha; Raul D Santos; Andrei Sposito; Mouaz H Al-Mallah; Ron Blankstein; Matthew J Budoff; Khurram Nasir Journal: BMC Public Health Date: 2014-01-08 Impact factor: 3.295
Authors: Candice A Myers; Tim Slack; Corby K Martin; Stephanie T Broyles; Steven B Heymsfield Journal: Obesity (Silver Spring) Date: 2014-12-17 Impact factor: 5.002
Authors: Katherine D Hoerster; Lamont Tanksley; Tracy Simpson; Brian E Saelens; Jürgen Unützer; Marissa Black; Preston Greene; Nadiyah Sulayman; Gayle Reiber; Karin Nelson Journal: Am J Health Promot Date: 2020-03-12
Authors: Sheila E Fleischhacker; Catherine E Woteki; Paul M Coates; Van S Hubbard; Grace E Flaherty; Daniel R Glickman; Thomas R Harkin; David Kessler; William W Li; Joseph Loscalzo; Anand Parekh; Sylvia Rowe; Patrick J Stover; Angie Tagtow; Anthony Joon Yun; Dariush Mozaffarian Journal: Am J Clin Nutr Date: 2020-09-01 Impact factor: 7.045
Authors: Albert Do; Denise A Esserman; Supriya Krishnan; Joseph K Lim; Tamar H Taddei; Ronald G Hauser; Janet P Tate; Vincent Lo Re; Amy C Justice Journal: J Gen Intern Med Date: 2020-04-27 Impact factor: 5.128
Authors: Jessica Y Breland; Susan M Frayne; Christine Timko; Donna L Washington; Shira Maguen Journal: Psychiatr Serv Date: 2020-01-30 Impact factor: 3.084
Authors: Dylan D Thomas; Molly E Waring; Omid Ameli; Joel I Reisman; Varsha G Vimalananda Journal: Obesity (Silver Spring) Date: 2019-05-15 Impact factor: 5.002